Cargando…

Immunoglobulin G4-Related Disease-Associated Dermatitis with Pruritus: A Positive Response to Dupilumab

Immunoglobulin G4-related disease (IgG4-RD) is a rare fibro-inflammatory condition characterized by IgG4-expressing plasma cell infiltration of the skin and other organs, leading to profound itchiness. Oral corticosteroids are the first-line therapy for IgG4-RD but relapses and potential side effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beck, Tyler C., Plante, John, Robinson, India, Khatskevich, Katsiaryna, Forcucci, Jessica A., Valdebran, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056512/ https://www.ncbi.nlm.nih.gov/pubmed/36983988 http://dx.doi.org/10.3390/life13030833

Ejemplares similares

Dupilumab for cancer-associated refractory pruritus
por: Talmon, Aviv, et al.
Publicado: (2023)

Recalcitrant anal and genital pruritus treated with dupilumab()()()()
por: Yang, E.J., et al.
Publicado: (2018)

The use of dupilumab for the treatment of recalcitrant brachioradial pruritus
por: Abel, Mary Kathryn, et al.
Publicado: (2021)

Dupilumab Failure in Treating Dermatomyositis-Associated Pruritus
por: O'Brien, Margaret A, et al.
Publicado: (2022)

Combination treatment of dupilumab with bortezomib in a patient with IgG kappa gammopathy of renal significance, uremic pruritus and chronic lichenoid dermatitis
por: Paolino, Giovanni, et al.
Publicado: (2023)

Chronic Pruritus Responding to Dupilumab—A Case Series
por: Zhai, Lisa L., et al.
Publicado: (2019)

Dupilumab for atopic dermatitis
Publicado: (2019)

A successful case of dupilumab treatment for severe uremic pruritus
por: Silverberg, Jonathan I., et al.
Publicado: (2019)

Dupilumab Improves Pruritus in Netherton Syndrome: A Case Study
por: Inaba, Yutaka, et al.
Publicado: (2022)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis
por: Spekhorst, Lotte S., et al.
Publicado: (2023)

Treatment efficacy of dupilumab in a hyper-immunoglobulin E syndrome patient with severe atopic dermatitis
por: Su, Chia-Jui, et al.
Publicado: (2021)

Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab
por: Wu, Chenyu, et al.
Publicado: (2023)

Refractory pruritus responds to dupilumab in a patient with TTC7A mutation
por: Alipour Tehrany, Yassaman, et al.
Publicado: (2020)

Argas reflexus dermatitis and nocturnal pruritus
por: Alipour Tehrany, Yassaman, et al.
Publicado: (2018)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
por: Gelato, Federica, et al.
Publicado: (2023)

A Case Report and Literature Review on Osseous Metaplasia in Traditional Serrated Adenoma
por: Mammadova, Jamila, et al.
Publicado: (2023)

Six cases of refractory pruritus and histologic dermal hypersensitivity reaction successfully treated with dupilumab
por: Edmonds, Nicole, et al.
Publicado: (2021)

Upadacitinib as a treatment for chronic pruritus secondary to polycythemia vera after failure with dupilumab
por: Wachuku, Christopher I., et al.
Publicado: (2023)

Alopecia areata after dupilumab for atopic dermatitis
por: Mitchell, Krystal, et al.
Publicado: (2018)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
por: Ferreira, Sandra, et al.
Publicado: (2020)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
por: Zubek, Amanda E., et al.
Publicado: (2020)

Practical Management of Patients with Atopic Dermatitis on Dupilumab
por: Papp, Kim A., et al.
Publicado: (2021)

Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
por: de Bruin-Weller, Marjolein, et al.
Publicado: (2021)

The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2021)

Improvement of atopic dermatitis and alopecia universalis with dupilumab
por: Alotaibi, Lama, et al.
Publicado: (2021)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
por: Shan, Jinpeng, et al.
Publicado: (2022)

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
por: Park, Jonathan J., et al.
Publicado: (2023)

Relapsing-remitting multiple sclerosis arising in a patient with atopic dermatitis on dupilumab
por: Laageide, Leah, et al.
Publicado: (2021)

Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus
por: Robinson, Warner, et al.
Publicado: (2023)

Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real‐life study
por: Mastorino, Luca, et al.
Publicado: (2021)

The evaluation of dupilumab treatment response in atopic dermatitis patients
por: Askin, Ozge, et al.
Publicado: (2020)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
por: Cho, Sung Kyung, et al.
Publicado: (2021)

Emerging Methods to Objectively Assess Pruritus in Atopic Dermatitis
por: Smith, Mary Patricia, et al.
Publicado: (2019)

Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab
por: Buttgereit, Thomas, et al.
Publicado: (2021)

Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients
por: Mastorino, Luca, et al.
Publicado: (2022)

Rapid resolution of widespread cutaneous lichen planus and generalized pruritus in an elderly patient following treatment with dupilumab
por: Kazemi, Soroush, et al.
Publicado: (2022)

Remarkable response to dupilumab in a 5-year-old patient with severe, recalcitrant atopic dermatitis
por: Johnson, Brian B., et al.
Publicado: (2019)

Clinical Psoriasiform Dermatitis Following Dupilumab Use for Autoeczematization Secondary to Chronic Stasis Dermatitis
por: Schrom, Kory P, et al.
Publicado: (2020)

Atopic Dermatitis with Multiple Comorbidities Treated with Dupilumab. A Case Report and Review of the Literature Regarding the Safety of Dupilumab
por: Mitroi, George G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_01ho7bbbk32jii9c3lj07m7o6j